Full-Time

Manager – Accounting Operations

Confirmed live in the last 24 hours

Penumbra Inc

Penumbra Inc

1,001-5,000 employees

Develops medical devices for vascular conditions

Compensation Overview

$140k - $170k/yr

+ Competitive Compensation Package + Equity Program

Senior, Expert

Company Historically Provides H1B Sponsorship

Alameda, CA, USA

Category
Financial Accounting
Management Accounting
Accounting
Required Skills
Word/Pages/Docs
Excel/Numbers/Sheets
Requirements
  • Bachelor's degree in Accounting/Finance or related field with 8+ years’ experience or an equivalent combination of education and experience
  • Comprehensive understanding of US GAAP and full cycle accounting experience
  • Accounting operations experience
  • Strong analytical abilities
  • Excellent communication skills
  • High degree of accuracy and attention to detail
  • Proficiency with MS Word, Excel, and PowerPoint
  • Excellent organizational skills with ability to prioritize assignments while handling various projects simultaneously
Responsibilities
  • Perform key parts of the month end close including analysis, reviewing journal entries, financial statement review, and account reconciliations
  • Select, manage, train, and develop direct reports including Fixed Assets and Travel & Expense teams
  • Provide technical accounting expertise and knowledge as appropriate
  • Ensure timely delivery of audit schedules and direct interface with external auditors
  • Ensure SOX compliance by monitoring accounting policies, procedures, and internal controls
  • Provide training to new and existing staff as needed
  • Support and participate in the timely reporting of financial results to management
  • Manage operational accounting metrics including cash forecast and trend analysis
  • Assist with development and implementation of new processes, systems, and various departmental initiatives
  • Adhere to the Company’s Quality Management System (QMS) as well as domestic and global quality system regulations, standards, and procedures
  • Understand relevant security, privacy and compliance principles and adhere to the regulations, standards, and procedures that are applicable to the Company
  • Ensure other members of the department follow the QMS, regulations, standards, and procedures
  • Perform other work-related duties as assigned
Desired Qualifications
  • CPA preferred, but not required
  • Public accounting preferred, but not required
  • Industry experience preferred, but not required
  • Medical device, pharmaceutical, biotech, or other regulated industry experience desired

Penumbra Inc. specializes in creating medical devices that treat conditions related to the brain and blood vessels. Their products include a variety of devices for neurovascular interventions, such as the Penumbra System and the Penumbra SMART COIL, which are used to address issues like strokes. For peripheral vascular diseases, they offer the Indigo System and related tools. These devices are sold to hospitals and clinics primarily in Europe and the Americas. What sets Penumbra apart from its competitors is its strong focus on research and development, allowing them to continuously improve their products to meet the needs of healthcare professionals. The company's goal is to provide effective and high-quality medical solutions that enhance patient care in neurology and vascular surgery.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Alameda, California

Founded

2004

Simplify Jobs

Simplify's Take

What believers are saying

  • FDA clearance of Ruby XL System enhances Penumbra's product portfolio.
  • Increased adoption of AI in medical imaging complements Penumbra's neurovascular devices.
  • Telemedicine growth offers new integration opportunities for Penumbra's devices.

What critics are saying

  • Increased competition may impact Penumbra's market share in neurovascular devices.
  • Don Kassing's retirement could create a temporary leadership gap.
  • Italian regulatory challenges may affect Penumbra's financial performance.

What makes Penumbra Inc unique

  • Penumbra offers a comprehensive range of neuro and peripheral vascular devices.
  • The company focuses on innovative solutions for stroke and neurovascular disease treatment.
  • Penumbra's global presence spans North America, Europe, Asia, and Australia.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Retirement Plan

401(k) Company Match

Paid Parental Leave

Paid Vacation

Paid Sick Leave

Paid Holidays

Growth & Insights and Company News

Headcount

6 month growth

-1%

1 year growth

0%

2 year growth

0%
Medical Device Network
Jun 6th, 2025
Penumbra announces FDA clearance and launch of detachable embolisation coil

Penumbra has introduced Ruby XL System, the detachable embolisation coil, which has also received clearance from the US Food and Drug Administration (FDA).

BioSpace
Apr 29th, 2025
Penumbra, Inc. to Present at the BofA Securities 2025 Health Care Conference

ALAMEDA, Calif., April 29, 2025 /PRNewswire/ - Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the BofA Securities 2025 Health Care Conference on Tuesday, May 13, 2025.

Neuro News International
Apr 24th, 2025
Penumbra announces Red 72 Silver Label product featuring company's latest engineering enhancements

Penumbra announces Red 72 Silver Label product featuring company's latest engineering enhancements.

PR Newswire
Apr 3rd, 2025
Penumbra, Inc. Schedules First Quarter 2025 Earnings Release And Conference Call For April 23, 2025

ALAMEDA, Calif., April 3, 2025 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial results for the first quarter 2025 after market close on Wednesday, April 23, 2025 at 4:30 PM Eastern Time. A press release with first quarter 2025 financial results will be issued after market close that day.Webcast & Conference Call InformationThe conference call can be accessed live over the phone by dialing (888) 596-4144 (conference id: 6572573), or the webcast can be accessed on the "Events and Presentations" section under the "Investors" tab of the Company's website at www.penumbrainc.com. The webcast will be available on the Company's website for at least two weeks following the completion of the call.About PenumbraPenumbra, Inc., the world's leading thrombectomy company, is focused on developing the most innovative technologies for challenging medical conditions such as ischemic stroke, venous thromboembolism such as pulmonary embolism, and acute limb ischemia. Our broad portfolio, which includes computer assisted vacuum thrombectomy (CAVT), centers on removing blood clots from head-to-toe with speed, safety and simplicity. By pioneering these innovations, we support healthcare providers, hospitals and clinics in more than 100 countries, working to improve patient outcomes and quality of life

Penumbrainc
Mar 17th, 2025
Latest Data on Penumbra's CAVT Technology to Be Presented at SIR 2025: STRIDE, STRIKE-PE, and More

Latest data on Penumbra's CAVT technology to be presented at SIR 2025: STRIDE, STRIKE-PE, and more.